World's Best Scientists 2026 revealed!
Olivier Schwartz

Olivier Schwartz

D-Index & Metrics

Immunology

D-Index
102
Citations
43531
World Ranking
665
National Ranking
21

Medicine

D-Index
102
Citations
43535
World Ranking
7589
National Ranking
236

Olivier Schwartz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Olivier Schwartz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 277 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Olivier Schwartz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Olivier Schwartz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 102 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2008 - Fellow of Alfred P. Sloan Foundation

Overview

Olivier Schwartz is affiliated with Université Paris Cité in France and has contributed extensively to medical research, particularly in the context of infectious diseases. Their publication record comprises 410 works in the field of Medicine, with a significant focus on infectious diseases, immunology, molecular biology, virology, and epidemiology.

The scientist's subfields of study include:

  • Infectious Diseases
  • Immunology
  • Molecular Biology
  • Virology
  • Epidemiology

Olivier Schwartz has centered much of their research around the SARS-CoV-2 virus and COVID-19, producing a substantial body of work on topics such as viral detection, immune cell function, and antibody research. Their main topics of work encompass:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • Monoclonal and Polyclonal Antibodies Research
  • Bacillus and Francisella bacterial research

The scientist has published frequently in several prominent venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Journal of Virology
  • iScience
  • Nature

Notable recent papers authored by Olivier Schwartz include:

  • Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization, 2021, Nature
  • Considerable escape of SARS-CoV-2 Omicron to antibody neutralization, 2021, Nature
  • IgA dominates the early neutralizing antibody response to SARS-CoV-2, 2020, Science Translational Medicine
  • Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies, 2021, Nature Medicine
  • Syncytia formation by SARS-CoV-2-infected cells, 2020, The EMBO Journal

Olivier Schwartz has collaborated frequently with several researchers in their field. Their most frequent co-authors include:

  • Timothée Bruel
  • Delphine Planas
  • Isabelle Staropoli
  • Hugo Mouquet
  • Françoise Porrot

In recognition of their contributions, Olivier Schwartz was awarded the title of Fellow of the Alfred P. Sloan Foundation in 2008.

Best Publications

  • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

    David E. Gordon;Gwendolyn M. Jang;Mehdi Bouhaddou;Jiewei Xu

  • The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

    Estelle Oberlin;Ali Amara;Franc˛oise Bachelerie;Christine Bessia

  • Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

    Delphine Planas;David Veyer;Artem Baidaliuk;Isabelle Staropoli

  • SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

    Nadine Laguette;Bijan Sobhian;Nicoletta Casartelli;Mathieu Ringeard

  • Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein

    O Schwartz;V Maréchal;S Le Gall;F Lemonnier

  • IgA dominates the early neutralizing antibody response to SARS-CoV-2.

    Delphine Sterlin;Delphine Sterlin;Alexis Mathian;Makoto Miyara;Audrey Mohr

  • Biology and pathogenesis of chikungunya virus

    Olivier Schwartz;Matthew L Albert

  • DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells

    Ludovic Tailleux;Olivier Schwartz;Jean-Louis Herrmann;Elisabeth Pivert

  • HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication

    Ali Amara;Sylvie Le Gall;Olivier Schwartz;Jean Salamero

  • Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

    Delphine Planas;Delphine Planas;Timothée Bruel;Timothée Bruel;Ludivine Grzelak;Florence Guivel-Benhassine;Florence Guivel-Benhassine

  • Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses

    Erika Navarro-Sanchez;Ralf Altmeyer;Ali Amara;Olivier Schwartz

  • Characterization of Reemerging Chikungunya Virus

    Marion Sourisseau;Clémentine Schilte;Nicoletta Casartelli;Céline Trouillet

  • The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry.

    Laurent Meertens;Xavier Carnec;Xavier Carnec;Manuel Perera Lecoin;Manuel Perera Lecoin;Rasika Ramdasi;Rasika Ramdasi

  • DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2

    Pierre-Yves Lozach;Hugues Lortat-Jacob;Agnès de Lacroix de Lavalette;Isabelle Staropoli

  • Nef Interacts with the μ Subunit of Clathrin Adaptor Complexes and Reveals a Cryptic Sorting Signal in MHC I Molecules

    Sylvie Le Gall;Lars Erdtmann;Serge Benichou;Clarisse Berlioz-Torrent

  • Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses

    Laurent Meertens;Laurent Meertens;Athena Labeau;Athena Labeau;Ophelie Dejarnac;Ophelie Dejarnac;Sara Cipriani

  • APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

    Cécile Esnault;Odile Heidmann;Frédéric Delebecque;Marie Dewannieux

  • Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis.

    Valérie Maréchal;Marie-Christine Prevost;Caroline Petit;Emmanuelle Perret

  • SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells.

    Benjamin Descours;Alexandra Cribier;Christine Chable-Bessia;Diana Ayinde

  • Syncytia formation by SARS-CoV-2-infected cells.

    Julian Buchrieser;Julian Buchrieser;Jérémy Dufloo;Jérémy Dufloo;Jérémy Dufloo;Mathieu Hubert;Mathieu Hubert;Blandine Monel;Blandine Monel

Frequent Co-Authors

Hugo Mouquet
Hugo Mouquet Institut Pasteur
Ali Amara
Ali Amara Université Paris Cité
Sylvie van der Werf
Sylvie van der Werf Université Paris Cité
Arnaud Fontanet
Arnaud Fontanet Institut Pasteur
Pierre Charneau
Pierre Charneau Institut Pasteur
James P. Di Santo
James P. Di Santo Institut Pasteur
Darragh Duffy
Darragh Duffy Institut Pasteur
Fernando Arenzana-Seisdedos
Fernando Arenzana-Seisdedos Chinese Academy of Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology but seeking a dynamic career in healthcare, exploring online nursing degrees can be a valuable step. Many students start with programs tailored for beginners, such as the best online bsn programs for non nurses. These programs provide foundational nursing knowledge and skills for individuals without prior experience in the field.

Accelerated options are also available, designed to help motivated students quickly transition into nursing roles. The accelerated bsn programs for non nurses offer a fast-track route, combining intensive coursework with clinical practice for rapid entry into nursing careers.

For those looking for entry-level positions in nursing, Licensed Practical Nurse (LPN) programs offer practical, career-focused training. Understanding which lpn programs are easiest to get into can help applicants select programs that balance accessibility with quality education, paving the way towards hands-on patient care roles.

Advancing further, nurse practitioner programs open doors to specialized clinical positions. Prospective students often seek out easy nurse practitioner programs to get into to find accessible pathways that still provide comprehensive training required for advanced practice nursing.

Overall, combining studies in Immunology with strategic degree choices can lead to diverse and rewarding healthcare careers.

Best Scientists Citing Olivier Schwartz

Trending Scientists

Recently Published Articles